Descriptors
Documents disponibles dans cette catégorie (335)


Extend search on down-posting(s)
Aanbevelingen in de Vlaamse huisartsenpraktijk / Paul Van Royen in Huisarts Nu, 31(2002)02 ([03/01/2002])
![]()
[article] Aanbevelingen in de Vlaamse huisartsenpraktijk : Een enquête naar gebruik en attitudes [printed text] / Paul Van Royen, Author ; Ann Van den Bruel, Author ; L. De Schampheleire, Author ; H.G. Van Bever, Author . - 2002 . - 78-85.
Languages : Dutch (dut)
in Huisarts Nu > 31(2002)02 [03/01/2002] . - 78-85
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Belgium ; Data Collection ; Health Care ; Hospitals ; Journal ArticleAbstract: Om de kwaliteit van de gezondheidszorg te bevorderen worden er voor de huisartsengeneeskundige praktijk steeds meer aanbevelingen of richtlijnen opgesteld. Welke houding hebben huisartsen tegenover dergelijke aanbevelingen? Zijn zij van oordeel dat die daadwerkelijk bijdragen tot een betere klinische zorg? Uit dit enquêteonderzoek onder 209 Vlaamse huisartsen blijkt dat de meeste huisartsen wel positief staan tegenover de aanbevelingen. Link for e-copy: http://www.domusmedica.be/onderzoek/huisartsnu/archief.html?start=35 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1820 [article]Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy / Irina Cleemput in Value in Health, 18(2015)04 ([06/01/2015])
![]()
[article] Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy : A Delphi Survey in Belgian Stakeholders [printed text] / Irina Cleemput, Author ; Wendy Christiaens
, Author ; Laurence Kohn
, Author ; Christian Léonard
, Author ; François Daue, Author ; Alain Denis, Author . - 2015 . - 477-483.
Languages : English (eng)
in Value in Health > 18(2015)04 [06/01/2015] . - 477-483
Descriptors: Indexation
2012-70 ; Belgium ; Journal Article ; Patient Participation ; Peer Review ; Policy ; Public Health ; R195 ; Stakeholder involvementAbstract: BACKGROUND:
In systems with public health insurance, coverage decisions should reflect social values. Deliberation among stakeholders could achieve this goal, but rarely involves patients and citizens directly.
OBJECTIVES:
This study aimed at evaluating the acceptability, and the perceived benefits and risks, of public and patient involvement (PPI) in coverage decision making to Belgian stakeholders.
METHODS:
A two-round Delphi survey was conducted among all stakeholder groups. The survey was constructed on the basis of interviews with 10 key stakeholders and a review of the literature on participation models. Consensus was defined as 65% or more of the respondents agreeing with a statement and less than 15% disagreeing. Eighty stakeholders participated in both rounds. They were defined as the Delphi panel.
RESULTS:
Belgian stakeholders are open toward PPI in coverage decision processes. Benefits are expected to exceed risks. The preferred model for involvement is to consult citizens or patients, within the existing decision-making structures and at specific milestones in the process. Consulting citizens and patients is a higher level of involvement than merely informing them and a lower level than letting them participate actively. Consultation involves asking nonbinding advice on (parts of) the decision problem. According to the Delphi panel, the benefits of PPI could be increasing awareness among members of the general public and patients about the challenges and costs of health care, and enriched decision processes with expertise by experience from patients. Potential risks include subjectivity, insufficient resources to participate and weigh on the process, difficulties in finding effective ways to express a collective opinion, the risk of manipulation, and lobbying or power games of other stakeholders.
CONCLUSIONS:
PPI in coverage decision-making processes is acceptable to Belgian stakeholders, be it in different ways for different types of decisions. Benefits are expected to outweigh risks.Link for e-copy: http://www.dx.doi.org/10.1016/j.jval.2014.12.015 Format of e-copy: PDF [Requires Subscription) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3671 [article]Accreditation in stroke units of 6 European regions / Ömer R. Saka in Cerebrovascular Diseases, 35(2013)Suppl.3 ([05/01/2013])
![]()
[article] Accreditation in stroke units of 6 European regions : One name different realities [printed text] / Ömer R. Saka, Author ; Ying Sun, Author ; D Michiels, Author ; Vincent Thijs, Author ; Dimitri Hemelsoet, Author ; Marijke Eyssen, Author ; Dominique Paulus
, Author . - 2013 . - 481.
Languages : English (eng)
in Cerebrovascular Diseases > 35(2013)Suppl.3 [05/01/2013] . - 481
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
2011-20 ; Belgium ; Cardiac Resynchronization Therapy Devices ; Emergency Treatment ; Journal Article ; Peer Review ; R181 ; StrokeAbstract: Background: ESO guidelines aim to promote standardised care of high quality in Europe but the organisation of acute care in stroke units (SU) largely differs between countries. This study aimed to scrutinize the accreditation or certification procedures of SU in 6 countries/regions: Scotland, Sweden, The Netherlands, France, Germany and the London Stroke Services (LSS). Methods: the information was collected with standardised questionnaires (25 pages) sent by mail to 12 experts from the 6 countries/regions. The research team analyzed the answers and clarified further issues by interviews. Results: an official mandatory accreditation procedure (organized and paid by governmental agencies) exists in Scotland, in LSS and in France. In Germany this procedure exists (private organizations) but is not mandatory. The accreditation process always implies at least site-visits and patient data review. Accreditation is renewed on a 1-, 3-, or 5-year basis. Some countries differentiate between types of SU (e.g. primary, comprehensive SU). The study further listed the criteria that SU must fulfil and the indicators measured for their accreditation (structure, process and outcome). Few of them refer to outcomes e.g. mortality, complications and recurrence. Incentives to encourage better quality differ between countries: public reporting of the results of the accreditation procedure, support to poor performers, benchmarking between hospitals, financial consequences. Conclusion: this exhaustive analysis gives an overview of the accreditation procedures in selected European countries. Care of high quality relies on a common evidence base but the quality assurance procedures, the indicators used as well as the consequences of the measurement largely differ between the countries. The question is to know if these various accreditation procedures result in differences in patients' outcomes. Link for e-copy: http://dx.doi.org/10.1159/000353129 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3779 [article]Adult obesity and number of years lived with and without cardiovascular disease / M.C. Pardo Silva in Obesity, 14(2006)7 ([07/01/2006])
![]()
[article] Adult obesity and number of years lived with and without cardiovascular disease [printed text] / M.C. Pardo Silva, Author ; Chris De Laet, Author ; W.J. Nusselder, Author ; A.A. Mamun, Author ; A. Peeters, Author . - 2006 . - 1264-73.
Languages : English (eng)
in Obesity > 14(2006)7 [07/01/2006] . - 1264-73
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Aging ; Body Mass Index ; Cardiovascular diseases ; Cost of Illness ; Female ; Humans ; Journal Article ; Life Expectancy ; Male ; Middle Aged ; Myocardial infarction ; Obesity ; Overweight ; Peer Review ; Risk Assessment ; Risk Factors ; Stroke ; Time Factors ; United StatesAbstract: OBJECTIVE: To determine the differences in number of years lived free of cardiovascular disease (CVD) and number of years lived with CVD between men and women who were obese, pre-obese, or normal weight at 45 years of age.
RESEARCH METHODS AND PROCEDURES: We constructed multistate life tables for CVD, myocardial infarction, and stroke, using data from 2551 enrollees (1130 men) in the Framingham Heart Study who were 45 years of age.
RESULTS: Obesity and pre-obesity were associated with fewer number of years free of CVD, myocardial infarction, and stroke and an increase in the number of years lived with these diseases. Forty-five-year-old obese men with no CVD survived 6.0 years [95% confidence interval (CI), 4.1; 8.1] fewer than their normal weight counterparts, whereas, for women, the difference between obese and normal weight subjects was 8.4 years (95% CI: 6.2; 10.8). Obese men and women lived with CVD 2.7 (95% CI: 1.0; 4.4) and 1.4 years (95% CI: -0.3; 3.2) longer, respectively, than normal weight individuals.
DISCUSSION: In addition to reducing life expectancy, obesity before middle age is associated with a reduction in the number of years lived free of CVD and an increase in the number of years lived with CVD. Such information is paramount for preventive and therapeutic decision-making by individuals and practitioners alike.Link for e-copy: http://www.nature.com/oby/journal/v14/n7/pdf/oby2006144a.pdf Format of e-copy: PDF [Open Access] (Embargo 2 years) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2154 [article]Age-related changes in human blood lymphocyte subpopulations / F. Erkeller-Yuksel in The Journal of Pediatrics, 120(1996)2 ([02/01/1996])
![]()
[article] Age-related changes in human blood lymphocyte subpopulations [printed text] / F. Erkeller-Yuksel, Author ; V. Deneys, Author ; B. Yuksel, Author ; I. Hannet, Author ; Frank Hulstaert, Author ; C. Hamilton, Author . - 1996 . - 216-222.
Languages : English (eng)
in The Journal of Pediatrics > 120(1996)2 [02/01/1996] . - 216-222
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Adolescent ; Adult ; Aged ; Aging ; Antigens, CD ; Child ; Child, Preschool ; Female ; Fetal Blood ; Humans ; Immunophenotyping ; Infant ; Journal Article ; Leukocyte Count ; Lymphocyte Subsets ; Male ; Middle Aged ; Peer Review ; United StatesAbstract: Flow cytometric analysis of major lymphocyte populations and their subsets reveals age-related changes in the cellular human immune system. Immunophenotypic markers were evaluated in 110 normal pediatric subjects, divided into groups of newborn infants, infants aged 2 days to 11 months, and children aged 1 to 6 years and 7 to 17 years; results were then compared with those obtained from 101 normal adults aged 18 to 70 years. Comparisons among age groups from newborn infants through adults reveal progressive declines in the absolute numbers of leukocytes, total lymphocytes, and T, B, and natural killer (NK) cells. The percentages of T cells within the total lymphocyte population increase with age, in both CD4+ and CD8+ subsets. Percentages of B and NK cells are higher in newborn infants than in adults. The expression of the activation markers interleukin-2R and HLA-DR on T cells increases with age, as does the NK-associated expression of CD57 on CD8 cells. The proportions of B lymphocytes that coexpress CD5 or CDw78 decrease with age, whereas expression of Leu-8 and CD23 increases. The proportion of CD4 cells bearing the CD45RA and Leu-8 markers is consistently lower in adults than in children. These data may serve as a reference range for studies of pediatric subjects. Link for e-copy: http://www.sciencedirect.com/science/journal/00223476 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2187 [article]Age-related changes in human blood lymphocyte subpopulations / Frank Hulstaert in Clinical immunology and immunopathology, 70(1994)02 ([02/01/1994])
![]()
PermalinkAlendronate or alfacalcidol in glucocorticoid-induced osteoporosis / R.N. de Nijs in The New England journal of medicine, 355(2006)7 ([08/17/2006])
![]()
PermalinkAlendroninezuur effectiever dan alfacalcidol voor preventie van osteoporose bij patiënten met een reumatische ziekte die starten met glucocorticoïdtherapie / R.N. de Nijs in Nederlands tijdschrift voor geneeskunde, 351(2007)21 ([05/26/2007])
![]()
PermalinkAllgemeine Gynäkologie. Frauenheilkunde und Geburtshilfe in Deutschland eine Marktübersicht im akutstationären Sektor / B. Augurzky, in Geburtshilfe und Frauenheilkunde, 69(2009)2 ([02/01/2009])
![]()
PermalinkAllgemeine Gynäkologie. Frauenheilkunde und Geburtshilfe in Deutschland / B. Augurzky, in Geburtshilfe und Frauenheilkunde, 69(2009)6 ([06/01/2009])
![]()
PermalinkAn economic evaluation of varicella vaccination in Italian adolescents / Nancy Thiry in Vaccine, 22(2004)27-28 ([09/09/2004])
![]()
PermalinkAn optimized method for routine HLA-B27 screening using flow cytometry / Frank Hulstaert in Cytometry, 18(1994)1 ([03/15/1994])
![]()
PermalinkAnalytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. / H. Vanderstichele in Clinical chemistry and laboratory medicine, 44(2006)12 ([01/01/2006])
![]()
PermalinkAntimicrobial prescribing by Belgian dentists in ambulatory care, from 2010 to 2016 / Thomas Struyf in International Dental Journal, 69(2019)06 ([12/02/2019])
![]()
PermalinkAre biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? / Maria-Isabel Farfan-Portet in European Journal of Health Economics (The), 15(2014)3 ([04/01/2014])
![]()
Permalink
